The leading conference on human genetics in Europe.
duet multiomics solution +modC
Unlock the full potential of your DNA sample with duet +modC. Get A, C, G, T plus modified cytosine in a single workflow.
- Conference
- biomodal presenter
- In partnership with Illumina
ESHG European Human Genetics Conference 2023
Learn about our new 5-letter sequencing technology – duet multiomics solution +modC – and discover the combinatorial power of genetics and epigenetics.
10 July 2023
to 13 July 2023
SEC Glasgow
, Exhibition Way, Glasgow G3 8YW
Visit biomodal at booth
#714
About the event
Presenting at the event
Simultaneous measurement of genetics and epigenetics enables new biological insight
Robert Crawford
Associate Director, Customer Collaborations
biomodal
Poster Presentation #P16.040.D
Dive deeper into how acquiring genetic and methylation data simultaneously produces higher quality calls that show how methylation promotes or silences specific alleles causing deregulation, altered expression, or potential disease.
Genetic and Epigenetic study of Formalin-damaged DNA
Fabio Puddu
Senior Bioinformatics Scientist
biomodal
Session PV04 | Poster Presentation #P16.044.D
Review performance of duet multiomics solution +modC for the detection of genetic and epigenetic sequence data at base resolution when using formalin damaged DNA. Samples include formalin-compromised DNA standards (fcDNA) as well as DNA extracted from formalin-fixed and paraffin-embedded (FFPE) samples of two colorectal cancer (CRC) patients.
Find the venue
One sample. One workflow. One solution.
Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.
Related resources
British Columbia Cancer Research Centre (BCCRC) & biomodal
The Aparicio lab at the British Columbia Cancer Research Centre (BCCRC) utilises 5-letter sequencing technology, duet multiomics solution +modC, to investigate ‘epigenetic rewiring’ in breast cancer cells.
High-quality information from FFPE samples: a genetic and epigenetic study of formalin-damaged DNA
Review performance of duet multiomics solution +modC for the detection of genetic and epigenetic sequence data at base resolution when using formalin damaged DNA. Samples include formalin-compromised DNA standards (fcDNA) as well as DNA extracted from formalin-fixed and paraffin-embedded (FFPE) samples of two colorectal cancer (CRC) patients.
Attending from biomodal
Peter Fromen
Chief Executive Officer
Páidí Creed, PhD
Vice President, Computational Technologies
Donna McDade Walker, PhD
Vice President, Global Marketing & Product Management
Register now
ESHG 2023
